Melvyn Little Ph.D. ā Founder and Consultant at Affimed N.V.
Executive Bio
Prof. Melvyn Little founded Affimed Therapeutics B.V. (now Affimed N.V.) in 2000 and has been its Consultant since January 1, 2012. Prof. Little served as Chief Scientific Officer of Affimed Therapeutics B.V. until January 2012. Prof. Little served as a Deputy Chief Executive Officer of Affimed Therapeutics B.V. He is qualified as lecturer in the Faculty of Biology, University of Heidelberg (???Habilitation???). Prof. Little is the Professor in the Faculty of Biology at University of Heidelberg. Prof. Little is the Head of the research group ???Recombinant Antibodies at the German Cancer Research Center (DKFZ) in Heidelberg and Invited speaker and keynote speaker to numerous international congresses on the subject of antibody engineering. Prof. Little received a Ph.D. from the University of Wales, Bangor.
Executive Team Culture Ratings from Affimed N.V. Employees
Affimed N.V. Executive Team at a Glance
Based on 12 ratings, Affimed N.V. employees rate their Executive Team 75/100.
×